nodes	percent_of_prediction	percent_of_DWPC	metapath
Repaglinide—PPARG—pancreatic cancer	0.521	1	CbGaD
Repaglinide—SLCO1B1—Irinotecan—pancreatic cancer	0.066	0.199	CbGbCtD
Repaglinide—ALB—Erlotinib—pancreatic cancer	0.0401	0.12	CbGbCtD
Repaglinide—CYP2C8—Tamoxifen—pancreatic cancer	0.0364	0.109	CbGbCtD
Repaglinide—ALB—Irinotecan—pancreatic cancer	0.0362	0.109	CbGbCtD
Repaglinide—ALB—Fluorouracil—pancreatic cancer	0.0347	0.104	CbGbCtD
Repaglinide—CYP2C8—Erlotinib—pancreatic cancer	0.0309	0.0931	CbGbCtD
Repaglinide—CYP2C8—Fluorouracil—pancreatic cancer	0.0268	0.0807	CbGbCtD
Repaglinide—CYP3A4—Tamoxifen—pancreatic cancer	0.0148	0.0444	CbGbCtD
Repaglinide—CYP3A4—Erlotinib—pancreatic cancer	0.0126	0.0377	CbGbCtD
Repaglinide—CYP3A4—Irinotecan—pancreatic cancer	0.0113	0.0341	CbGbCtD
Repaglinide—CYP3A4—Docetaxel—pancreatic cancer	0.00831	0.025	CbGbCtD
Repaglinide—CYP3A4—Sunitinib—pancreatic cancer	0.00827	0.0249	CbGbCtD
Repaglinide—CYP3A4—Doxorubicin—pancreatic cancer	0.00619	0.0186	CbGbCtD
Repaglinide—PPARG—Topotecan—Irinotecan—pancreatic cancer	0.00343	1	CbGdCrCtD
Repaglinide—Alopecia—Gemcitabine—pancreatic cancer	0.000336	0.0028	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.000336	0.00279	CcSEcCtD
Repaglinide—Arrhythmia—Fluorouracil—pancreatic cancer	0.000334	0.00278	CcSEcCtD
Repaglinide—Constipation—Erlotinib—pancreatic cancer	0.000332	0.00277	CcSEcCtD
Repaglinide—Erythema—Gemcitabine—pancreatic cancer	0.000331	0.00275	CcSEcCtD
Repaglinide—Alopecia—Fluorouracil—pancreatic cancer	0.00033	0.00275	CcSEcCtD
Repaglinide—Thrombocytopenia—Sunitinib—pancreatic cancer	0.000329	0.00274	CcSEcCtD
Repaglinide—Back pain—Irinotecan—pancreatic cancer	0.000329	0.00274	CcSEcCtD
Repaglinide—Angina pectoris—Docetaxel—pancreatic cancer	0.000328	0.00273	CcSEcCtD
Repaglinide—Skin disorder—Sunitinib—pancreatic cancer	0.000327	0.00272	CcSEcCtD
Repaglinide—Erythema—Fluorouracil—pancreatic cancer	0.000325	0.00271	CcSEcCtD
Repaglinide—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.000321	0.00267	CcSEcCtD
Repaglinide—Back pain—Gemcitabine—pancreatic cancer	0.00032	0.00266	CcSEcCtD
Repaglinide—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.000318	0.00265	CcSEcCtD
Repaglinide—Urticaria—Tamoxifen—pancreatic cancer	0.000312	0.0026	CcSEcCtD
Repaglinide—Abdominal pain—Tamoxifen—pancreatic cancer	0.000311	0.00259	CcSEcCtD
Repaglinide—Abdominal pain—Erlotinib—pancreatic cancer	0.000307	0.00256	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.000307	0.00255	CcSEcCtD
Repaglinide—Leukopenia—Irinotecan—pancreatic cancer	0.000304	0.00253	CcSEcCtD
Repaglinide—Paraesthesia—Sunitinib—pancreatic cancer	0.000302	0.00252	CcSEcCtD
Repaglinide—Hepatic function abnormal—Epirubicin—pancreatic cancer	0.000301	0.00251	CcSEcCtD
Repaglinide—Stevens-Johnson syndrome—Docetaxel—pancreatic cancer	0.000298	0.00248	CcSEcCtD
Repaglinide—Dyspepsia—Sunitinib—pancreatic cancer	0.000296	0.00247	CcSEcCtD
Repaglinide—Acute coronary syndrome—Docetaxel—pancreatic cancer	0.000296	0.00247	CcSEcCtD
Repaglinide—Leukopenia—Gemcitabine—pancreatic cancer	0.000296	0.00247	CcSEcCtD
Repaglinide—Myocardial infarction—Docetaxel—pancreatic cancer	0.000294	0.00245	CcSEcCtD
Repaglinide—Hypertension—Irinotecan—pancreatic cancer	0.000293	0.00244	CcSEcCtD
Repaglinide—Jaundice—Docetaxel—pancreatic cancer	0.000293	0.00244	CcSEcCtD
Repaglinide—Leukopenia—Fluorouracil—pancreatic cancer	0.000291	0.00242	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000291	0.00242	CcSEcCtD
Repaglinide—Cardiac failure congestive—Epirubicin—pancreatic cancer	0.00029	0.00241	CcSEcCtD
Repaglinide—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000289	0.00241	CcSEcCtD
Repaglinide—Constipation—Sunitinib—pancreatic cancer	0.000288	0.0024	CcSEcCtD
Repaglinide—Hypertension—Gemcitabine—pancreatic cancer	0.000286	0.00238	CcSEcCtD
Repaglinide—Hepatobiliary disease—Docetaxel—pancreatic cancer	0.000284	0.00237	CcSEcCtD
Repaglinide—Arthralgia—Gemcitabine—pancreatic cancer	0.000282	0.00235	CcSEcCtD
Repaglinide—Chest pain—Gemcitabine—pancreatic cancer	0.000282	0.00235	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.00028	0.00233	CcSEcCtD
Repaglinide—Hepatic function abnormal—Doxorubicin—pancreatic cancer	0.000278	0.00232	CcSEcCtD
Repaglinide—Pruritus—Tamoxifen—pancreatic cancer	0.000278	0.00231	CcSEcCtD
Repaglinide—Anaphylactic shock—Irinotecan—pancreatic cancer	0.000277	0.00231	CcSEcCtD
Repaglinide—Oedema—Irinotecan—pancreatic cancer	0.000277	0.00231	CcSEcCtD
Repaglinide—Chest pain—Fluorouracil—pancreatic cancer	0.000277	0.00231	CcSEcCtD
Repaglinide—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000275	0.00229	CcSEcCtD
Repaglinide—Pruritus—Erlotinib—pancreatic cancer	0.000275	0.00229	CcSEcCtD
Repaglinide—Anaphylactoid reaction—Epirubicin—pancreatic cancer	0.000272	0.00226	CcSEcCtD
Repaglinide—Thrombocytopenia—Irinotecan—pancreatic cancer	0.000271	0.00226	CcSEcCtD
Repaglinide—Rhinitis—Docetaxel—pancreatic cancer	0.00027	0.00225	CcSEcCtD
Repaglinide—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.00027	0.00225	CcSEcCtD
Repaglinide—Oedema—Gemcitabine—pancreatic cancer	0.00027	0.00225	CcSEcCtD
Repaglinide—Hepatitis—Docetaxel—pancreatic cancer	0.00027	0.00225	CcSEcCtD
Repaglinide—Hypoglycaemia—Epirubicin—pancreatic cancer	0.000269	0.00224	CcSEcCtD
Repaglinide—Diarrhoea—Tamoxifen—pancreatic cancer	0.000269	0.00224	CcSEcCtD
Repaglinide—Cardiac failure congestive—Doxorubicin—pancreatic cancer	0.000268	0.00223	CcSEcCtD
Repaglinide—Abdominal pain—Sunitinib—pancreatic cancer	0.000266	0.00221	CcSEcCtD
Repaglinide—Diarrhoea—Erlotinib—pancreatic cancer	0.000266	0.00221	CcSEcCtD
Repaglinide—Oedema peripheral—Docetaxel—pancreatic cancer	0.000266	0.00221	CcSEcCtD
Repaglinide—Oedema—Fluorouracil—pancreatic cancer	0.000265	0.00221	CcSEcCtD
Repaglinide—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000265	0.00221	CcSEcCtD
Repaglinide—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000264	0.0022	CcSEcCtD
Repaglinide—Skin disorder—Gemcitabine—pancreatic cancer	0.000262	0.00218	CcSEcCtD
Repaglinide—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.00026	0.00216	CcSEcCtD
Repaglinide—Visual impairment—Docetaxel—pancreatic cancer	0.00026	0.00216	CcSEcCtD
Repaglinide—Erythema multiforme—Docetaxel—pancreatic cancer	0.000255	0.00212	CcSEcCtD
Repaglinide—Eye disorder—Docetaxel—pancreatic cancer	0.000252	0.0021	CcSEcCtD
Repaglinide—Anaphylactoid reaction—Doxorubicin—pancreatic cancer	0.000251	0.00209	CcSEcCtD
Repaglinide—Cardiac disorder—Docetaxel—pancreatic cancer	0.00025	0.00208	CcSEcCtD
Repaglinide—Vomiting—Tamoxifen—pancreatic cancer	0.00025	0.00208	CcSEcCtD
Repaglinide—Hypoglycaemia—Doxorubicin—pancreatic cancer	0.000249	0.00208	CcSEcCtD
Repaglinide—Paraesthesia—Irinotecan—pancreatic cancer	0.000249	0.00207	CcSEcCtD
Repaglinide—Hypersensitivity—Sunitinib—pancreatic cancer	0.000248	0.00206	CcSEcCtD
Repaglinide—Rash—Tamoxifen—pancreatic cancer	0.000248	0.00206	CcSEcCtD
Repaglinide—Dermatitis—Tamoxifen—pancreatic cancer	0.000247	0.00206	CcSEcCtD
Repaglinide—Vomiting—Erlotinib—pancreatic cancer	0.000247	0.00206	CcSEcCtD
Repaglinide—Headache—Tamoxifen—pancreatic cancer	0.000246	0.00205	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000246	0.00205	CcSEcCtD
Repaglinide—Rash—Erlotinib—pancreatic cancer	0.000245	0.00204	CcSEcCtD
Repaglinide—Dermatitis—Erlotinib—pancreatic cancer	0.000245	0.00204	CcSEcCtD
Repaglinide—Dyspepsia—Irinotecan—pancreatic cancer	0.000244	0.00203	CcSEcCtD
Repaglinide—Immune system disorder—Docetaxel—pancreatic cancer	0.000244	0.00203	CcSEcCtD
Repaglinide—Headache—Erlotinib—pancreatic cancer	0.000244	0.00203	CcSEcCtD
Repaglinide—Paraesthesia—Gemcitabine—pancreatic cancer	0.000242	0.00202	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000242	0.00201	CcSEcCtD
Repaglinide—Arrhythmia—Docetaxel—pancreatic cancer	0.000241	0.00201	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000239	0.00199	CcSEcCtD
Repaglinide—Paraesthesia—Fluorouracil—pancreatic cancer	0.000238	0.00198	CcSEcCtD
Repaglinide—Alopecia—Docetaxel—pancreatic cancer	0.000238	0.00198	CcSEcCtD
Repaglinide—Pruritus—Sunitinib—pancreatic cancer	0.000238	0.00198	CcSEcCtD
Repaglinide—Constipation—Irinotecan—pancreatic cancer	0.000237	0.00197	CcSEcCtD
Repaglinide—Erythema—Docetaxel—pancreatic cancer	0.000235	0.00195	CcSEcCtD
Repaglinide—Malnutrition—Docetaxel—pancreatic cancer	0.000235	0.00195	CcSEcCtD
Repaglinide—Dyspepsia—Fluorouracil—pancreatic cancer	0.000234	0.00195	CcSEcCtD
Repaglinide—Nausea—Tamoxifen—pancreatic cancer	0.000233	0.00194	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000233	0.00194	CcSEcCtD
Repaglinide—Constipation—Gemcitabine—pancreatic cancer	0.000231	0.00192	CcSEcCtD
Repaglinide—Nausea—Erlotinib—pancreatic cancer	0.000231	0.00192	CcSEcCtD
Repaglinide—Diarrhoea—Sunitinib—pancreatic cancer	0.00023	0.00192	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000229	0.00191	CcSEcCtD
Repaglinide—Back pain—Docetaxel—pancreatic cancer	0.000227	0.00189	CcSEcCtD
Repaglinide—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000227	0.00189	CcSEcCtD
Repaglinide—Pancreatitis—Epirubicin—pancreatic cancer	0.000223	0.00186	CcSEcCtD
Repaglinide—Angina pectoris—Epirubicin—pancreatic cancer	0.000221	0.00184	CcSEcCtD
Repaglinide—Abdominal pain—Irinotecan—pancreatic cancer	0.000219	0.00182	CcSEcCtD
Repaglinide—Bronchitis—Epirubicin—pancreatic cancer	0.000219	0.00182	CcSEcCtD
Repaglinide—Vomiting—Sunitinib—pancreatic cancer	0.000214	0.00178	CcSEcCtD
Repaglinide—Rash—Sunitinib—pancreatic cancer	0.000212	0.00177	CcSEcCtD
Repaglinide—Dermatitis—Sunitinib—pancreatic cancer	0.000212	0.00176	CcSEcCtD
Repaglinide—Urticaria—Fluorouracil—pancreatic cancer	0.000211	0.00176	CcSEcCtD
Repaglinide—Headache—Sunitinib—pancreatic cancer	0.000211	0.00176	CcSEcCtD
Repaglinide—Leukopenia—Docetaxel—pancreatic cancer	0.00021	0.00175	CcSEcCtD
Repaglinide—Palpitations—Docetaxel—pancreatic cancer	0.000207	0.00173	CcSEcCtD
Repaglinide—Pancreatitis—Doxorubicin—pancreatic cancer	0.000206	0.00172	CcSEcCtD
Repaglinide—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000205	0.00171	CcSEcCtD
Repaglinide—Angina pectoris—Doxorubicin—pancreatic cancer	0.000205	0.00171	CcSEcCtD
Repaglinide—Hypersensitivity—Irinotecan—pancreatic cancer	0.000204	0.0017	CcSEcCtD
Repaglinide—Hypertension—Docetaxel—pancreatic cancer	0.000203	0.00169	CcSEcCtD
Repaglinide—Bronchitis—Doxorubicin—pancreatic cancer	0.000202	0.00168	CcSEcCtD
Repaglinide—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000201	0.00167	CcSEcCtD
Repaglinide—Arthralgia—Docetaxel—pancreatic cancer	0.0002	0.00166	CcSEcCtD
Repaglinide—Chest pain—Docetaxel—pancreatic cancer	0.0002	0.00166	CcSEcCtD
Repaglinide—Nausea—Sunitinib—pancreatic cancer	0.0002	0.00166	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000198	0.00165	CcSEcCtD
Repaglinide—Jaundice—Epirubicin—pancreatic cancer	0.000198	0.00164	CcSEcCtD
Repaglinide—Urinary tract infection—Epirubicin—pancreatic cancer	0.000197	0.00164	CcSEcCtD
Repaglinide—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000196	0.00163	CcSEcCtD
Repaglinide—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000192	0.0016	CcSEcCtD
Repaglinide—Oedema—Docetaxel—pancreatic cancer	0.000192	0.0016	CcSEcCtD
Repaglinide—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000192	0.0016	CcSEcCtD
Repaglinide—Pruritus—Gemcitabine—pancreatic cancer	0.000191	0.00159	CcSEcCtD
Repaglinide—Sinusitis—Epirubicin—pancreatic cancer	0.00019	0.00158	CcSEcCtD
Repaglinide—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.00019	0.00158	CcSEcCtD
Repaglinide—Diarrhoea—Irinotecan—pancreatic cancer	0.00019	0.00158	CcSEcCtD
Repaglinide—Pruritus—Fluorouracil—pancreatic cancer	0.000188	0.00156	CcSEcCtD
Repaglinide—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000188	0.00156	CcSEcCtD
Repaglinide—Skin disorder—Docetaxel—pancreatic cancer	0.000186	0.00155	CcSEcCtD
Repaglinide—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000186	0.00155	CcSEcCtD
Repaglinide—Diarrhoea—Gemcitabine—pancreatic cancer	0.000185	0.00154	CcSEcCtD
Repaglinide—Jaundice—Doxorubicin—pancreatic cancer	0.000183	0.00152	CcSEcCtD
Repaglinide—Rhinitis—Epirubicin—pancreatic cancer	0.000182	0.00152	CcSEcCtD
Repaglinide—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000182	0.00152	CcSEcCtD
Repaglinide—Hepatitis—Epirubicin—pancreatic cancer	0.000182	0.00151	CcSEcCtD
Repaglinide—Diarrhoea—Fluorouracil—pancreatic cancer	0.000182	0.00151	CcSEcCtD
Repaglinide—Oedema peripheral—Epirubicin—pancreatic cancer	0.000179	0.00149	CcSEcCtD
Repaglinide—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000177	0.00148	CcSEcCtD
Repaglinide—Vomiting—Irinotecan—pancreatic cancer	0.000176	0.00147	CcSEcCtD
Repaglinide—Sinusitis—Doxorubicin—pancreatic cancer	0.000176	0.00146	CcSEcCtD
Repaglinide—Visual impairment—Epirubicin—pancreatic cancer	0.000175	0.00146	CcSEcCtD
Repaglinide—Rash—Irinotecan—pancreatic cancer	0.000175	0.00146	CcSEcCtD
Repaglinide—Dermatitis—Irinotecan—pancreatic cancer	0.000175	0.00145	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000175	0.00145	CcSEcCtD
Repaglinide—Headache—Irinotecan—pancreatic cancer	0.000174	0.00145	CcSEcCtD
Repaglinide—Paraesthesia—Docetaxel—pancreatic cancer	0.000172	0.00143	CcSEcCtD
Repaglinide—Erythema multiforme—Epirubicin—pancreatic cancer	0.000172	0.00143	CcSEcCtD
Repaglinide—Vomiting—Gemcitabine—pancreatic cancer	0.000172	0.00143	CcSEcCtD
Repaglinide—Rash—Gemcitabine—pancreatic cancer	0.00017	0.00142	CcSEcCtD
Repaglinide—Dermatitis—Gemcitabine—pancreatic cancer	0.00017	0.00142	CcSEcCtD
Repaglinide—Eye disorder—Epirubicin—pancreatic cancer	0.00017	0.00142	CcSEcCtD
Repaglinide—Headache—Gemcitabine—pancreatic cancer	0.000169	0.00141	CcSEcCtD
Repaglinide—Cardiac disorder—Epirubicin—pancreatic cancer	0.000169	0.00141	CcSEcCtD
Repaglinide—Vomiting—Fluorouracil—pancreatic cancer	0.000169	0.00141	CcSEcCtD
Repaglinide—Rhinitis—Doxorubicin—pancreatic cancer	0.000169	0.0014	CcSEcCtD
Repaglinide—Dyspepsia—Docetaxel—pancreatic cancer	0.000169	0.0014	CcSEcCtD
Repaglinide—Hepatitis—Doxorubicin—pancreatic cancer	0.000168	0.0014	CcSEcCtD
Repaglinide—Rash—Fluorouracil—pancreatic cancer	0.000167	0.00139	CcSEcCtD
Repaglinide—Dermatitis—Fluorouracil—pancreatic cancer	0.000167	0.00139	CcSEcCtD
Repaglinide—Headache—Fluorouracil—pancreatic cancer	0.000166	0.00138	CcSEcCtD
Repaglinide—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000166	0.00138	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000165	0.00138	CcSEcCtD
Repaglinide—Nausea—Irinotecan—pancreatic cancer	0.000165	0.00137	CcSEcCtD
Repaglinide—Immune system disorder—Epirubicin—pancreatic cancer	0.000164	0.00137	CcSEcCtD
Repaglinide—Constipation—Docetaxel—pancreatic cancer	0.000164	0.00136	CcSEcCtD
Repaglinide—Arrhythmia—Epirubicin—pancreatic cancer	0.000163	0.00135	CcSEcCtD
Repaglinide—Visual impairment—Doxorubicin—pancreatic cancer	0.000162	0.00135	CcSEcCtD
Repaglinide—Alopecia—Epirubicin—pancreatic cancer	0.000161	0.00134	CcSEcCtD
Repaglinide—Nausea—Gemcitabine—pancreatic cancer	0.00016	0.00134	CcSEcCtD
Repaglinide—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000159	0.00133	CcSEcCtD
Repaglinide—Erythema—Epirubicin—pancreatic cancer	0.000158	0.00132	CcSEcCtD
Repaglinide—Malnutrition—Epirubicin—pancreatic cancer	0.000158	0.00132	CcSEcCtD
Repaglinide—Nausea—Fluorouracil—pancreatic cancer	0.000158	0.00131	CcSEcCtD
Repaglinide—Eye disorder—Doxorubicin—pancreatic cancer	0.000157	0.00131	CcSEcCtD
Repaglinide—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000157	0.0013	CcSEcCtD
Repaglinide—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000156	0.0013	CcSEcCtD
Repaglinide—Back pain—Epirubicin—pancreatic cancer	0.000153	0.00128	CcSEcCtD
Repaglinide—Immune system disorder—Doxorubicin—pancreatic cancer	0.000152	0.00127	CcSEcCtD
Repaglinide—Abdominal pain—Docetaxel—pancreatic cancer	0.000151	0.00126	CcSEcCtD
Repaglinide—Arrhythmia—Doxorubicin—pancreatic cancer	0.00015	0.00125	CcSEcCtD
Repaglinide—Alopecia—Doxorubicin—pancreatic cancer	0.000149	0.00124	CcSEcCtD
Repaglinide—Erythema—Doxorubicin—pancreatic cancer	0.000147	0.00122	CcSEcCtD
Repaglinide—Malnutrition—Doxorubicin—pancreatic cancer	0.000147	0.00122	CcSEcCtD
Repaglinide—Leukopenia—Epirubicin—pancreatic cancer	0.000142	0.00118	CcSEcCtD
Repaglinide—Back pain—Doxorubicin—pancreatic cancer	0.000142	0.00118	CcSEcCtD
Repaglinide—Hypersensitivity—Docetaxel—pancreatic cancer	0.000141	0.00118	CcSEcCtD
Repaglinide—Palpitations—Epirubicin—pancreatic cancer	0.00014	0.00117	CcSEcCtD
Repaglinide—Hypertension—Epirubicin—pancreatic cancer	0.000137	0.00114	CcSEcCtD
Repaglinide—Pruritus—Docetaxel—pancreatic cancer	0.000136	0.00113	CcSEcCtD
Repaglinide—Arthralgia—Epirubicin—pancreatic cancer	0.000135	0.00112	CcSEcCtD
Repaglinide—Chest pain—Epirubicin—pancreatic cancer	0.000135	0.00112	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000134	0.00111	CcSEcCtD
Repaglinide—Leukopenia—Doxorubicin—pancreatic cancer	0.000131	0.00109	CcSEcCtD
Repaglinide—Diarrhoea—Docetaxel—pancreatic cancer	0.000131	0.00109	CcSEcCtD
Repaglinide—Palpitations—Doxorubicin—pancreatic cancer	0.000129	0.00108	CcSEcCtD
Repaglinide—Oedema—Epirubicin—pancreatic cancer	0.000129	0.00108	CcSEcCtD
Repaglinide—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000129	0.00108	CcSEcCtD
Repaglinide—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000127	0.00105	CcSEcCtD
Repaglinide—Hypertension—Doxorubicin—pancreatic cancer	0.000126	0.00105	CcSEcCtD
Repaglinide—Skin disorder—Epirubicin—pancreatic cancer	0.000126	0.00105	CcSEcCtD
Repaglinide—Arthralgia—Doxorubicin—pancreatic cancer	0.000125	0.00104	CcSEcCtD
Repaglinide—Chest pain—Doxorubicin—pancreatic cancer	0.000125	0.00104	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000124	0.00103	CcSEcCtD
Repaglinide—Vomiting—Docetaxel—pancreatic cancer	0.000122	0.00101	CcSEcCtD
Repaglinide—Rash—Docetaxel—pancreatic cancer	0.000121	0.00101	CcSEcCtD
Repaglinide—Dermatitis—Docetaxel—pancreatic cancer	0.000121	0.001	CcSEcCtD
Repaglinide—Headache—Docetaxel—pancreatic cancer	0.00012	0.000999	CcSEcCtD
Repaglinide—Oedema—Doxorubicin—pancreatic cancer	0.00012	0.000996	CcSEcCtD
Repaglinide—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.00012	0.000996	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000118	0.00098	CcSEcCtD
Repaglinide—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000117	0.000975	CcSEcCtD
Repaglinide—Skin disorder—Doxorubicin—pancreatic cancer	0.000116	0.000967	CcSEcCtD
Repaglinide—Paraesthesia—Epirubicin—pancreatic cancer	0.000116	0.000966	CcSEcCtD
Repaglinide—Nausea—Docetaxel—pancreatic cancer	0.000114	0.000948	CcSEcCtD
Repaglinide—Dyspepsia—Epirubicin—pancreatic cancer	0.000114	0.000947	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000112	0.000929	CcSEcCtD
Repaglinide—Constipation—Epirubicin—pancreatic cancer	0.000111	0.00092	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000109	0.000907	CcSEcCtD
Repaglinide—Paraesthesia—Doxorubicin—pancreatic cancer	0.000107	0.000894	CcSEcCtD
Repaglinide—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000106	0.00088	CcSEcCtD
Repaglinide—Dyspepsia—Doxorubicin—pancreatic cancer	0.000105	0.000876	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000103	0.00086	CcSEcCtD
Repaglinide—Urticaria—Epirubicin—pancreatic cancer	0.000103	0.000855	CcSEcCtD
Repaglinide—Constipation—Doxorubicin—pancreatic cancer	0.000102	0.000851	CcSEcCtD
Repaglinide—Abdominal pain—Epirubicin—pancreatic cancer	0.000102	0.000851	CcSEcCtD
Repaglinide—Gastrointestinal pain—Doxorubicin—pancreatic cancer	9.78e-05	0.000814	CcSEcCtD
Repaglinide—Hypersensitivity—Epirubicin—pancreatic cancer	9.52e-05	0.000793	CcSEcCtD
Repaglinide—Urticaria—Doxorubicin—pancreatic cancer	9.5e-05	0.000791	CcSEcCtD
Repaglinide—Abdominal pain—Doxorubicin—pancreatic cancer	9.45e-05	0.000787	CcSEcCtD
Repaglinide—Pruritus—Epirubicin—pancreatic cancer	9.14e-05	0.000761	CcSEcCtD
Repaglinide—Diarrhoea—Epirubicin—pancreatic cancer	8.84e-05	0.000736	CcSEcCtD
Repaglinide—Hypersensitivity—Doxorubicin—pancreatic cancer	8.81e-05	0.000734	CcSEcCtD
Repaglinide—Pruritus—Doxorubicin—pancreatic cancer	8.46e-05	0.000704	CcSEcCtD
Repaglinide—Vomiting—Epirubicin—pancreatic cancer	8.22e-05	0.000684	CcSEcCtD
Repaglinide—Diarrhoea—Doxorubicin—pancreatic cancer	8.18e-05	0.000681	CcSEcCtD
Repaglinide—Rash—Epirubicin—pancreatic cancer	8.15e-05	0.000678	CcSEcCtD
Repaglinide—Dermatitis—Epirubicin—pancreatic cancer	8.14e-05	0.000678	CcSEcCtD
Repaglinide—Headache—Epirubicin—pancreatic cancer	8.1e-05	0.000674	CcSEcCtD
Repaglinide—Nausea—Epirubicin—pancreatic cancer	7.68e-05	0.000639	CcSEcCtD
Repaglinide—Vomiting—Doxorubicin—pancreatic cancer	7.6e-05	0.000633	CcSEcCtD
Repaglinide—Rash—Doxorubicin—pancreatic cancer	7.54e-05	0.000628	CcSEcCtD
Repaglinide—Dermatitis—Doxorubicin—pancreatic cancer	7.53e-05	0.000627	CcSEcCtD
Repaglinide—Headache—Doxorubicin—pancreatic cancer	7.49e-05	0.000624	CcSEcCtD
Repaglinide—Nausea—Doxorubicin—pancreatic cancer	7.1e-05	0.000591	CcSEcCtD
Repaglinide—PPARG—Developmental Biology—IAPP—pancreatic cancer	5.38e-05	0.00233	CbGpPWpGaD
Repaglinide—CYP2C8—Arachidonic acid metabolism—PTGS2—pancreatic cancer	5.37e-05	0.00232	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PRSS1—pancreatic cancer	5.36e-05	0.00232	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—NR5A2—pancreatic cancer	5.09e-05	0.0022	CbGpPWpGaD
Repaglinide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	4.99e-05	0.00216	CbGpPWpGaD
Repaglinide—PPARG—Adipogenesis—CTNNB1—pancreatic cancer	4.94e-05	0.00214	CbGpPWpGaD
Repaglinide—PPARG—Generic Transcription Pathway—NOTCH3—pancreatic cancer	4.89e-05	0.00212	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—ARG2—pancreatic cancer	4.79e-05	0.00207	CbGpPWpGaD
Repaglinide—ALB—Platelet degranulation—EGF—pancreatic cancer	4.77e-05	0.00206	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—ARG2—pancreatic cancer	4.64e-05	0.00201	CbGpPWpGaD
Repaglinide—PPARG—SREBP signalling—AKT1—pancreatic cancer	4.61e-05	0.00199	CbGpPWpGaD
Repaglinide—ALB—Response to elevated platelet cytosolic Ca2+—EGF—pancreatic cancer	4.55e-05	0.00197	CbGpPWpGaD
Repaglinide—PPARG—Adipogenesis—STAT3—pancreatic cancer	4.31e-05	0.00186	CbGpPWpGaD
Repaglinide—ALB—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	4.27e-05	0.00185	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—TYMP—pancreatic cancer	4.19e-05	0.00181	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—TYMP—pancreatic cancer	4.06e-05	0.00176	CbGpPWpGaD
Repaglinide—PPARG—Adipogenesis—TGFB1—pancreatic cancer	3.99e-05	0.00173	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PRSS1—pancreatic cancer	3.96e-05	0.00171	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	3.8e-05	0.00164	CbGpPWpGaD
Repaglinide—PPARG—Adipogenesis—TNF—pancreatic cancer	3.73e-05	0.00161	CbGpPWpGaD
Repaglinide—PPARG—Generic Transcription Pathway—SMAD4—pancreatic cancer	3.69e-05	0.00159	CbGpPWpGaD
Repaglinide—ALB—Vitamin B12 Metabolism—TNF—pancreatic cancer	3.55e-05	0.00153	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—SMAD4—pancreatic cancer	3.47e-05	0.0015	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—ARG2—pancreatic cancer	3.43e-05	0.00148	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—IFNA5—pancreatic cancer	3.43e-05	0.00148	CbGpPWpGaD
Repaglinide—PPARG—Circadian rythm related genes—PTEN—pancreatic cancer	3.4e-05	0.00147	CbGpPWpGaD
Repaglinide—ALB—Selenium Micronutrient Network—PTGS2—pancreatic cancer	3.4e-05	0.00147	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—HES1—pancreatic cancer	3.39e-05	0.00147	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—GLP1R—pancreatic cancer	3.37e-05	0.00146	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—DPYD—pancreatic cancer	3.32e-05	0.00144	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—GLP1R—pancreatic cancer	3.27e-05	0.00141	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—PPP2R5B—pancreatic cancer	3.24e-05	0.0014	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—DPYD—pancreatic cancer	3.22e-05	0.00139	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—SLC2A2—pancreatic cancer	3.15e-05	0.00136	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PRSS1—pancreatic cancer	3.12e-05	0.00135	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—SLC2A2—pancreatic cancer	3.05e-05	0.00132	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—TYMP—pancreatic cancer	3e-05	0.0013	CbGpPWpGaD
Repaglinide—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—pancreatic cancer	2.97e-05	0.00129	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—MEN1—pancreatic cancer	2.92e-05	0.00126	CbGpPWpGaD
Repaglinide—ALB—Platelet degranulation—VEGFA—pancreatic cancer	2.89e-05	0.00125	CbGpPWpGaD
Repaglinide—ALB—Folate Metabolism—TNF—pancreatic cancer	2.89e-05	0.00125	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—NOTCH4—pancreatic cancer	2.77e-05	0.0012	CbGpPWpGaD
Repaglinide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—pancreatic cancer	2.75e-05	0.00119	CbGpPWpGaD
Repaglinide—PPARG—Generic Transcription Pathway—NOTCH1—pancreatic cancer	2.72e-05	0.00118	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—KDR—pancreatic cancer	2.72e-05	0.00117	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—ARG2—pancreatic cancer	2.7e-05	0.00117	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—MET—pancreatic cancer	2.66e-05	0.00115	CbGpPWpGaD
Repaglinide—ALB—Platelet degranulation—TGFB1—pancreatic cancer	2.65e-05	0.00115	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—HSPA1B—pancreatic cancer	2.64e-05	0.00114	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—NOTCH1—pancreatic cancer	2.56e-05	0.00111	CbGpPWpGaD
Repaglinide—ALB—Folate Metabolism—TP53—pancreatic cancer	2.54e-05	0.0011	CbGpPWpGaD
Repaglinide—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—pancreatic cancer	2.52e-05	0.00109	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2.48e-05	0.00107	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—CD44—pancreatic cancer	2.44e-05	0.00105	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—GLP1R—pancreatic cancer	2.42e-05	0.00105	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—EZH2—pancreatic cancer	2.41e-05	0.00104	CbGpPWpGaD
Repaglinide—ABCC8—Neuronal System—HRAS—pancreatic cancer	2.38e-05	0.00103	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—DPYD—pancreatic cancer	2.38e-05	0.00103	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—CD44—pancreatic cancer	2.37e-05	0.00102	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—TYMP—pancreatic cancer	2.36e-05	0.00102	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—NOTCH3—pancreatic cancer	2.36e-05	0.00102	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—GCG—pancreatic cancer	2.34e-05	0.00101	CbGpPWpGaD
Repaglinide—PPARG—Circadian rythm related genes—TP53—pancreatic cancer	2.32e-05	0.001	CbGpPWpGaD
Repaglinide—KCNJ11—Neuronal System—HRAS—pancreatic cancer	2.31e-05	0.000999	CbGpPWpGaD
Repaglinide—ALB—Selenium Micronutrient Network—TNF—pancreatic cancer	2.29e-05	0.000992	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—GCG—pancreatic cancer	2.27e-05	0.000981	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—SLC2A2—pancreatic cancer	2.26e-05	0.000976	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.23e-05	0.000966	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—HSPA1A—pancreatic cancer	2.23e-05	0.000965	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—MMP2—pancreatic cancer	2.22e-05	0.000958	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—STK11—pancreatic cancer	2.2e-05	0.000951	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	2.17e-05	0.000938	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—PIK3CG—pancreatic cancer	2.14e-05	0.000926	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—STK11—pancreatic cancer	2.13e-05	0.000922	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—EGF—pancreatic cancer	2.12e-05	0.000915	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.96e-05	0.000849	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.95e-05	0.000843	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—CD44—pancreatic cancer	1.94e-05	0.000839	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—GLP1R—pancreatic cancer	1.9e-05	0.000823	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—TYMS—pancreatic cancer	1.89e-05	0.000818	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—PIK3CD—pancreatic cancer	1.88e-05	0.000814	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—IFNA1—pancreatic cancer	1.88e-05	0.000812	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—DPYD—pancreatic cancer	1.87e-05	0.00081	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—TYMS—pancreatic cancer	1.83e-05	0.000793	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PRSS1—pancreatic cancer	1.79e-05	0.000774	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PRSS1—pancreatic cancer	1.78e-05	0.00077	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—SLC2A2—pancreatic cancer	1.78e-05	0.000769	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—SMAD4—pancreatic cancer	1.77e-05	0.000767	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.76e-05	0.000761	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—IFNA2—pancreatic cancer	1.75e-05	0.000756	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—CD44—pancreatic cancer	1.75e-05	0.000756	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.71e-05	0.00074	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—CTNNB1—pancreatic cancer	1.7e-05	0.000735	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.7e-05	0.000734	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.7e-05	0.000733	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—GCG—pancreatic cancer	1.68e-05	0.000725	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—MMP9—pancreatic cancer	1.67e-05	0.00072	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—PIK3CB—pancreatic cancer	1.64e-05	0.00071	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—STK11—pancreatic cancer	1.58e-05	0.000681	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ARG2—pancreatic cancer	1.55e-05	0.000671	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.55e-05	0.000669	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ARG2—pancreatic cancer	1.54e-05	0.000668	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—APOE—pancreatic cancer	1.54e-05	0.000665	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—SRC—pancreatic cancer	1.54e-05	0.000664	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—VEGFA—pancreatic cancer	1.5e-05	0.000647	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—APOE—pancreatic cancer	1.49e-05	0.000645	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—STAT3—pancreatic cancer	1.48e-05	0.00064	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.48e-05	0.00064	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—NRAS—pancreatic cancer	1.48e-05	0.000639	CbGpPWpGaD
Repaglinide—PPARG—Generic Transcription Pathway—MYC—pancreatic cancer	1.46e-05	0.000632	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PIK3CG—pancreatic cancer	1.39e-05	0.0006	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—CD44—pancreatic cancer	1.38e-05	0.000595	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—TGFB1—pancreatic cancer	1.37e-05	0.000594	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—TYMP—pancreatic cancer	1.36e-05	0.000587	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—TYMS—pancreatic cancer	1.36e-05	0.000586	CbGpPWpGaD
Repaglinide—ALB—Metabolism—TYMP—pancreatic cancer	1.35e-05	0.000584	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.35e-05	0.000583	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—EGFR—pancreatic cancer	1.35e-05	0.000582	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PIK3CG—pancreatic cancer	1.35e-05	0.000582	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PPARG—pancreatic cancer	1.34e-05	0.000579	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.34e-05	0.000578	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—GCG—pancreatic cancer	1.32e-05	0.000571	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—SRC—pancreatic cancer	1.32e-05	0.000569	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—NOTCH1—pancreatic cancer	1.31e-05	0.000566	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PPARG—pancreatic cancer	1.3e-05	0.000562	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—TNF—pancreatic cancer	1.28e-05	0.000554	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—VEGFA—pancreatic cancer	1.28e-05	0.000554	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—KRAS—pancreatic cancer	1.27e-05	0.00055	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—PLAU—pancreatic cancer	1.24e-05	0.000537	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—STK11—pancreatic cancer	1.24e-05	0.000537	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PIK3CD—pancreatic cancer	1.22e-05	0.000528	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PIK3CD—pancreatic cancer	1.18e-05	0.000512	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—TGFB1—pancreatic cancer	1.18e-05	0.000508	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.16e-05	0.000504	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.12e-05	0.000484	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.11e-05	0.000482	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—PIK3CG—pancreatic cancer	1.1e-05	0.000477	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—APOE—pancreatic cancer	1.1e-05	0.000477	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GLP1R—pancreatic cancer	1.09e-05	0.000473	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—EGF—pancreatic cancer	1.09e-05	0.000472	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GLP1R—pancreatic cancer	1.09e-05	0.00047	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—HRAS—pancreatic cancer	1.08e-05	0.000467	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—DPYD—pancreatic cancer	1.08e-05	0.000465	CbGpPWpGaD
Repaglinide—ALB—Metabolism—DPYD—pancreatic cancer	1.07e-05	0.000463	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—TYMS—pancreatic cancer	1.07e-05	0.000462	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PIK3CB—pancreatic cancer	1.06e-05	0.00046	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PTGS2—pancreatic cancer	1.05e-05	0.000456	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.04e-05	0.000451	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PIK3CB—pancreatic cancer	1.03e-05	0.000446	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PTGS2—pancreatic cancer	1.02e-05	0.000442	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—SLC2A2—pancreatic cancer	1.02e-05	0.000442	CbGpPWpGaD
Repaglinide—ALB—Metabolism—SLC2A2—pancreatic cancer	1.02e-05	0.000439	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.01e-05	0.000437	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.01e-05	0.000435	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	1e-05	0.000433	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PIK3CG—pancreatic cancer	9.95e-06	0.00043	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	9.76e-06	0.000422	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—PIK3CD—pancreatic cancer	9.71e-06	0.00042	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	9.7e-06	0.000419	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PRSS1—pancreatic cancer	9.61e-06	0.000416	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—AKT1—pancreatic cancer	9.54e-06	0.000413	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PTEN—pancreatic cancer	9.19e-06	0.000397	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PTEN—pancreatic cancer	8.91e-06	0.000385	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	8.89e-06	0.000384	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	8.84e-06	0.000382	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PIK3CD—pancreatic cancer	8.75e-06	0.000378	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—APOE—pancreatic cancer	8.68e-06	0.000375	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—PIK3CB—pancreatic cancer	8.46e-06	0.000366	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ARG2—pancreatic cancer	8.34e-06	0.00036	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	8.22e-06	0.000355	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	8.17e-06	0.000353	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CD44—pancreatic cancer	7.91e-06	0.000342	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CD44—pancreatic cancer	7.86e-06	0.00034	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PIK3CG—pancreatic cancer	7.83e-06	0.000339	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	7.75e-06	0.000335	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	7.7e-06	0.000333	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	7.67e-06	0.000332	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	7.63e-06	0.00033	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PIK3CB—pancreatic cancer	7.62e-06	0.00033	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GCG—pancreatic cancer	7.58e-06	0.000328	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PPARG—pancreatic cancer	7.56e-06	0.000327	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PTGS2—pancreatic cancer	7.55e-06	0.000327	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GCG—pancreatic cancer	7.54e-06	0.000326	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—TYMP—pancreatic cancer	7.29e-06	0.000315	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—STK11—pancreatic cancer	7.13e-06	0.000308	CbGpPWpGaD
Repaglinide—ALB—Metabolism—STK11—pancreatic cancer	7.09e-06	0.000307	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—MYC—pancreatic cancer	7.04e-06	0.000304	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PIK3CD—pancreatic cancer	6.89e-06	0.000298	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—SRC—pancreatic cancer	6.78e-06	0.000293	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	6.69e-06	0.000289	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	6.65e-06	0.000288	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—VEGFA—pancreatic cancer	6.6e-06	0.000285	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PTEN—pancreatic cancer	6.59e-06	0.000285	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—NRAS—pancreatic cancer	6.52e-06	0.000282	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PIK3CA—pancreatic cancer	6.48e-06	0.00028	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PIK3CA—pancreatic cancer	6.29e-06	0.000272	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—TYMS—pancreatic cancer	6.13e-06	0.000265	CbGpPWpGaD
Repaglinide—ALB—Metabolism—TYMS—pancreatic cancer	6.1e-06	0.000264	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—TGFB1—pancreatic cancer	6.06e-06	0.000262	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PIK3CB—pancreatic cancer	6e-06	0.00026	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PTGS2—pancreatic cancer	5.95e-06	0.000257	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GLP1R—pancreatic cancer	5.87e-06	0.000254	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—DPYD—pancreatic cancer	5.78e-06	0.00025	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—KRAS—pancreatic cancer	5.61e-06	0.000243	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	5.48e-06	0.000237	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—AKT1—pancreatic cancer	5.3e-06	0.000229	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PTEN—pancreatic cancer	5.19e-06	0.000224	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—PIK3CA—pancreatic cancer	5.16e-06	0.000223	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—AKT1—pancreatic cancer	5.14e-06	0.000222	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—TP53—pancreatic cancer	4.99e-06	0.000216	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—APOE—pancreatic cancer	4.99e-06	0.000216	CbGpPWpGaD
Repaglinide—ALB—Metabolism—APOE—pancreatic cancer	4.96e-06	0.000214	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—AKT1—pancreatic cancer	4.88e-06	0.000211	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—HRAS—pancreatic cancer	4.77e-06	0.000206	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.72e-06	0.000204	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.69e-06	0.000203	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PIK3CA—pancreatic cancer	4.65e-06	0.000201	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PIK3CG—pancreatic cancer	4.5e-06	0.000195	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PIK3CG—pancreatic cancer	4.48e-06	0.000194	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PPARG—pancreatic cancer	4.34e-06	0.000188	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PPARG—pancreatic cancer	4.32e-06	0.000187	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CD44—pancreatic cancer	4.25e-06	0.000184	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—AKT1—pancreatic cancer	4.21e-06	0.000182	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GCG—pancreatic cancer	4.07e-06	0.000176	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	3.96e-06	0.000171	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PIK3CD—pancreatic cancer	3.93e-06	0.00017	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—STK11—pancreatic cancer	3.83e-06	0.000165	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—AKT1—pancreatic cancer	3.8e-06	0.000164	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PIK3CA—pancreatic cancer	3.66e-06	0.000158	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	3.45e-06	0.000149	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PIK3CB—pancreatic cancer	3.43e-06	0.000148	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PTGS2—pancreatic cancer	3.42e-06	0.000148	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PTGS2—pancreatic cancer	3.4e-06	0.000147	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—TYMS—pancreatic cancer	3.29e-06	0.000142	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—AKT1—pancreatic cancer	2.99e-06	0.000129	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PTEN—pancreatic cancer	2.98e-06	0.000129	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PTEN—pancreatic cancer	2.96e-06	0.000128	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—APOE—pancreatic cancer	2.68e-06	0.000116	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	2.42e-06	0.000104	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PPARG—pancreatic cancer	2.33e-06	0.000101	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	2.12e-06	9.18e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	2.1e-06	9.09e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PIK3CA—pancreatic cancer	2.09e-06	9.04e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	1.85e-06	8.01e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PTGS2—pancreatic cancer	1.83e-06	7.93e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—AKT1—pancreatic cancer	1.72e-06	7.43e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—AKT1—pancreatic cancer	1.71e-06	7.39e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PTEN—pancreatic cancer	1.6e-06	6.92e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.13e-06	4.88e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—AKT1—pancreatic cancer	9.22e-07	3.99e-05	CbGpPWpGaD
